BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010–2013: An observational study using state cancer registry and All‐Payer claims data

BACKGROUND: Testing for BRCA1/2 pathogenic variants is recommended for women aged ≤45 years with breast cancer. Some studies have found racial/ethnic and socioeconomic disparities in testing. We linked Massachusetts' All‐Payer Claims Database with Massachusetts Cancer Registry data to assess fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pace, Lydia E., Ayanian, John Z., Wolf, Robert E., Knowlton, Richard, Gershman, Susan T., Hawkins, Summer Sherburne, Keating, Nancy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249986/
https://www.ncbi.nlm.nih.gov/pubmed/35312162
http://dx.doi.org/10.1002/cam4.4648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249986/
https://www.ncbi.nlm.nih.gov/pubmed/35312162
http://dx.doi.org/10.1002/cam4.4648

Ejemplares similares